A nationwide recall of several DermaRite soap and skin products was issued after bacterial contamination was detected, posing serious infection risks and potential for life-threatening sepsis.
At a Glance
- DermaRite Industries recalled four soap and skin care products due to Burkholderia cepacia contamination
- The bacteria can cause severe infections, especially in immunocompromised individuals
- Products were distributed in the U.S. and Puerto Rico to both consumers and healthcare facilities
- No illnesses have been reported as of August 12, 2025
- FDA urges immediate discontinuation and safe disposal of affected lots
Recall Overview
On August 8, 2025, DermaRite Industries, LLC initiated a voluntary nationwide recall of multiple over-the-counter hygiene and skin care products after routine testing revealed contamination with Burkholderia cepacia, a bacteria commonly found in soil and water. The recall was announced in coordination with the U.S. Food and Drug Administration and applies to four product lines: DermaKleen, DermaSarra, KleenFoam, and PeriGiene.
The affected products were sold and distributed through healthcare facilities, retailers, and online vendors across the United States and Puerto Rico. Due to the bacteria’s natural resistance to several antibiotics, exposure can result in severe infection, particularly in individuals with weakened immune systems, chronic lung conditions, or open wounds.
Watch now: Walmart Hand Soap Recall Over Dangerous Bacteria · YouTube
Potential Health Impact
While Burkholderia cepacia may not cause illness in healthy individuals, it can lead to bloodstream infections, pneumonia, urinary tract infections, and in severe cases, sepsis—a potentially life-threatening condition. Even in people with no known underlying conditions, localized infections could occur if the bacteria enters through cuts or abrasions.
The CDC has previously noted outbreaks of B. cepacia linked to contaminated healthcare products, including mouthwashes and saline flushes. Healthcare environments are particularly at risk because of the high concentration of immunocompromised patients, making the recall significant for hospitals, long-term care facilities, and rehabilitation centers.
Action Steps for Consumers and Providers
The FDA advises all consumers, caregivers, and healthcare providers to immediately discontinue use of any recalled products and dispose of them following local waste guidelines. DermaRite has provided instructions for identifying affected lot numbers and expiration dates, which can be cross-referenced on the official recall notice.
As of the latest update, no illnesses have been reported, but anyone who has used the affected products and develops symptoms such as fever, chills, shortness of breath, or signs of localized infection should seek prompt medical attention. Reports of adverse events can be submitted through the FDA’s MedWatch program. DermaRite is offering direct customer support for inquiries related to the recall via telephone and email during business hours.
Sources
Click this link for the original source of this article.
Author: Editor
This content is courtesy of, and owned and copyrighted by, https://thecongressionalinsider.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
